|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00295048 |
|
Date of registration:
|
19/02/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Cognitive Remediation for Schizophrenia
|
|
Scientific title:
|
Cognitive Remediation for Schizophrenia |
|
Date of first enrolment:
|
November 2004 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00295048 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Dwight Dickinson, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Maryland |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Diagnosis of either schizophrenia or schizoaffective disorder according to DSM-IV criteria
2. Age 18 through 50
3. Subjects will be clinically stable as judged by current outpatient or inpatient treatment staff
4. Primary psychiatric medication is a new generation antipsychotic other than Clozapine and/or a dose of first generation antipsychotic equivalent to 10 mg. of less of haloperidol for one month prior to enrollment.
Exclusion Criteria:
1. Documented history of organic brain disease
2. Documented history of mental retardation
3. Physical limitations (e.g., with hearing or vision) that would interfere substantially with use of computer-based exercises
4. Diagnosis of current Substance Dependence according to DSM-IV criteria
5. Participation in the prior full trial of this remediation program (this exclusion is meant to apply to individuals participating in the full controlled trial, and not to individuals participating in the preliminary sub-study).
Age minimum:
18 Years
Age maximum:
50 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Schizophrenia
|
|
Intervention(s)
|
|
Behavioral: Computer Assisted Cognitive Remediation (CACR)
|
|
Primary Outcome(s)
|
|
broad cognitive performance (as indexed by a composite of the neuropsychological measures) and on a composite of everyday problem solving
|
|
Secondary Outcome(s)
|
|
individual cognitive domains and individual everyday problem solving domains, the interaction of treatment with various other variables
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|